Loading clinical trials...
Loading clinical trials...
phase II study of weekly metronomic chemotherapy using weekly Paclitaxel, Oxaliplatin, Leucovorin and 5-FU (POLF) in patients with advanced gastric cancer
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Huashan Hospital
Collaborators
NCT07102901 · Advanced Gastric Cancer, Metastatic Gastric Cancer, and more
NCT06768463 · Metastatic Gastric Cancer, Gastric Cancer, and more
NCT06773312 · Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
NCT06478394 · 1. Locally Advanced Gastric Cancer (LAGC): The Primary Condition Under Investigation is Locally Advanced Gastric Cancer, Which Refers to Stomach
NCT05714124 · Hepatocellular Carcinoma, Cholangiocarcinoma, and more
Seattle Integrative Cancer Center
Seattle, Washington
Huashan Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions